http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6416747-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dafb5bbc2ec47ebcb7becbbe60f704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C61-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-487
filingDate 1987-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41f2aebd233ca56fc5383c3afc4c294c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9adfb6c7c1ca68c4c82ee0193ef047
publicationDate 1989-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6416747-A
titleOfInvention Method for optically resolving (+-)-cis-permethric acid
abstract PURPOSE:To resolve (+ or -)-cis-permethric acid and (-)-cis-permethric acid in good yield and high purity, by treating (+ or -)-cis-permethric acid using a specific optical resolution agent. CONSTITUTION:An optically active 1-(p-tolyl)ethylamine or optically active cis-N-benzyl-2-(hydroxymethyl)cyclohexylamine is added to (+ or -)-cis-permethric acid and the mixture is dissolved in a solvent such as methanol while heating and cooled to give supersaturation and a diastereoisomer is deposited. Then the diastereoisomer is treated with a base and further reacted with an acid to provided the aimed product. The above-mentioned optical resolution agent is used at an amount of 0.8-1 equivalent based on the (+ or -)-cis-permethric acid.
priorityDate 1987-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5559133-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S56133244-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59134747-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S56108737-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59210045-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5533440-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414847683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226598924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID562744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226598148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226598926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID577386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID853690

Total number of triples: 30.